Component

Human N1-acetylpolyamine oxidase / PAOX

Context-specific entity; species, compartment and exposure are stated on each claim.

4 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. PAOX/SMOX knockout reduced polyamine-associated sensitization to ferroptosis in A549 and HT1080 cells.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary full text
    experimental_model
    Human cancer-cell genetic experiments; mixed polyamine comparisons.
    limitations
    Polyamine-class result; do not attribute all experiments to spermidine alone.
    nutrient_topic
    Spermidine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Spermidine
    plain_language
    Oxidative breakdown provides another route to lipid injury.
    primary_references
    Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38504107/ · DOI 10.1038/s41467-024-46776-w
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Spermidine: biosynthesis, hypusination, transport and cross-nutrient mechanisms (2026-09-19) · lines 534–540

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell genetic experiments; mixed polyamine comparisons. · source_derived_draft · unverified_draft

    ## spermidine-oxidase-ferroptosis Oxidative breakdown provides another route to lipid injury. PAOX/SMOX knockout reduced polyamine-associated sensitization to ferroptosis in A549 and HT1080 cells. Model: Human cancer-cell genetic experiments; mixed polyamine comparisons. Limitations: Polyamine-class result; do not attribute all experiments to spermidine alone. Evidence access: Primary full text Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38504107/ · DOI 10.1038/s41467-024-46776-w
    Complete structured claim and evidence
  2. Recombinant human PAOX oxidized N1-acetylspermidine with Km 2.1 micromolar and kcat 15 per second.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Purified human enzyme.
    limitations
    Do not apply these values to unmodified spermidine or a human plasma target.
    nutrient_topic
    Spermidine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Spermidine
    plain_language
    The acetylated molecule has its own enzyme kinetics.
    primary_references
    Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15791459/ · DOI 10.1007/s00280-004-0936-5

    Spermidine: biosynthesis, hypusination, transport and cross-nutrient mechanisms (2026-09-19) · lines 94–100

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human enzyme. · source_derived_draft · unverified_draft

    ## spermidine-paox-acetylspermidine The acetylated molecule has its own enzyme kinetics. Recombinant human PAOX oxidized N1-acetylspermidine with Km 2.1 micromolar and kcat 15 per second. Model: Purified human enzyme. Limitations: Do not apply these values to unmodified spermidine or a human plasma target. Evidence access: Primary abstract Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15791459/ · DOI 10.1007/s00280-004-0936-5
    Complete structured claim and evidence
  3. Human PAOX oxidized N1-acetylspermine with Km 0.85 micromolar and kcat 31.7 per second.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Purified human enzyme.
    limitations
    Substrate specificity differs from SMOX; enzyme turnover is not whole-body turnover.
    nutrient_topic
    Spermidine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Spermidine
    plain_language
    Back-conversion depends on which polyamine was acetylated.
    primary_references
    Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15791459/ · DOI 10.1007/s00280-004-0936-5

    Spermidine: biosynthesis, hypusination, transport and cross-nutrient mechanisms (2026-09-19) · lines 102–108

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human enzyme. · source_derived_draft · unverified_draft

    ## spermidine-paox-acetylspermine Back-conversion depends on which polyamine was acetylated. Human PAOX oxidized N1-acetylspermine with Km 0.85 micromolar and kcat 31.7 per second. Model: Purified human enzyme. Limitations: Substrate specificity differs from SMOX; enzyme turnover is not whole-body turnover. Evidence access: Primary abstract Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15791459/ · DOI 10.1007/s00280-004-0936-5
    Complete structured claim and evidence
  4. The recombinant human PAOX preparation did not efficiently oxidize unacetylated spermine.

    Human N1-acetylpolyamine oxidase / PAOX → Spermine source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Purified enzyme comparison.
    limitations
    Do not substitute PAOX for SMOX in the graph.
    nutrient_topic
    Spermidine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Spermidine
    plain_language
    Acetylation changes substrate recognition.
    primary_references
    Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15791459/ · DOI 10.1007/s00280-004-0936-5

    Spermidine: biosynthesis, hypusination, transport and cross-nutrient mechanisms (2026-09-19) · lines 110–116

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified enzyme comparison. · source_derived_draft · unverified_draft

    ## spermidine-paox-spermine-null Acetylation changes substrate recognition. The recombinant human PAOX preparation did not efficiently oxidize unacetylated spermine. Model: Purified enzyme comparison. Limitations: Do not substitute PAOX for SMOX in the graph. Evidence access: Primary abstract Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15791459/ · DOI 10.1007/s00280-004-0936-5
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards